SV Health Investors

SV Health Investors is a transatlantic healthcare investment platform with specialist teams across biotechnology, dementia, medtech, and healthcare growth.

Official website

Healthcare and biotechnology venture capital investor
Healthcare & BioTech Venture Capital
Tier III

Overview

SV Health Investors is a transatlantic healthcare investment platform with specialist teams across biotechnology, dementia, medtech, and healthcare growth. Its long history and diversified fund structure allow it to invest across development stages while retaining a clear healthcare identity.

The platform combines venture financing with company-building, clinical, operating, and growth expertise. Its Boston and London teams connect US and UK scientific and healthcare markets and support cross-border development and syndication. Within The Economy Wiki, the institution is connected to the Healthcare & Biotechnology Venture Capital market category.

Firm facts

Institution	SV Health Investors
Type	Healthcare and biotechnology venture capital investor
Headquarters	Boston / London, United States / United Kingdom
Founded	1993
Primary ranking focus	Healthcare & BioTech Venture Capital
Highest 2026 tier	Tier III

Contents

Activities and investment capabilities
Strategy and market coverage
Market position
Competitive context
Leadership and governance
Corporate and public information
Ranking recognition
Related Economy analysis
Related institutions and subjects
Sources

Activities and investment capabilities

SV Health Investors operates within life-sciences innovation, clinical development and healthcare company building. Its category-specific capabilities are summarized below.

Life-sciences investing

Capital for therapeutics, diagnostics, medical devices and research platforms.

Clinical development

Support across scientific validation, trials, regulation and commercialization.

Healthcare innovation

Investment in care delivery, health technology and data-enabled medical businesses.

Strategy and market coverage

Stage and strategy coverage

Company formation through growth; translational research; clinical and commercial financing

Sector and market coverage

Biotechnology; therapeutics; diagnostics; medtech; digital health and healthcare services

Market position

SV Health Investors fits Tier III because parts of its platform extend into growth equity and buyouts rather than venture alone. Its healthcare specialization, long continuity, active biotech and medtech franchises, and substantial institutional base make exclusion difficult to justify.

SV Health Investors is assessed within the Healthcare & Biotechnology Venture Capital framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

SV Health Investors is recognized Tier III in Top 30 Healthcare & BioTech Venture Capital 2026. The rankings compare institutions by market relevance, investment or operating capability, sector and stage expertise, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every company, fund commitment or transaction.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through the institution’s official website.

Leadership area	Current source
Investment and operating leadership	Current team and governance information

Corporate and public information

This profile refers to SV Health Investors as the public-facing organization. Individual funds, management companies, advisers, lending entities, broker-dealers and regulated affiliates may use separate legal names across jurisdictions.

Corporate and disclosure information

Organization	SV Health Investors
Headquarters	Boston / London, United States / United Kingdom
Public website	svhealthinvestors.com
Profile basis	Public institutional information and Capital Ranking editorial research